Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

9.08
BATS BZX Real-Time Price
As of 3:20pm ET
 +0.15 / +1.68%
Today’s Change
2.56
Today|||52-Week Range
10.45
+62.72%
Year-to-Date
Shark Bites: Stock Picking Makes a Comeback
Sep 23 / TheStreet.com - Paid Partner Content
This Rally Is No Fun at All
Sep 22 / TheStreet.com - Paid Partner Content
Are Investors Barking up the Wrong Tree With This Pure-Play Pet Stock?
Sep 22 / MotleyFool.com - Paid Partner Content
Shark Bites: Putting Etsy in My Basket
Sep 21 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close8.93
Today’s open8.99
Day’s range8.95 - 9.20
Volume35,631
Average volume (3 months)667,226
Market cap$316.3M
Dividend yield--
Data as of 3:20pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-88.46%
Earnings growth (this year)+68.50%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.60%
P/E ratioNM
Price/Sales282.75
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
CLSDClearside Biomedical...+1.52+9.96%
ARLZAralez Pharmaceutica...-0.13-2.48%
IDRAIdera Pharmaceutical...-0.18-6.77%
AQXPAquinox Pharmaceutic...-0.04-0.28%
Data as of 3:22pm ET, 09/27/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$678.0K
Annual profit (last year)-$84.1M
Net profit margin-12,397.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Operating Officer
Brent A. Standridge
Corporate headquarters
Leawood, Kansas

Forecasts

Search for Jobs